These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 11402952

  • 1. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
    Torricelli P, Montanari N, Spina V, Manfrini M, Bertoni F, Saguatti G, Romagnoli R.
    Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
    [Abstract] [Full Text] [Related]

  • 2. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]

  • 3. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AH, Nooy MA, Hogendoorn PC.
    AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 5. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
    de Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, di Paola M.
    Radiology; 1992 Nov; 185(2):587-92. PubMed ID: 1410378
    [Abstract] [Full Text] [Related]

  • 6. Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma.
    Onikul E, Fletcher BD, Parham DM, Chen G.
    AJR Am J Roentgenol; 1996 Nov; 167(5):1211-5. PubMed ID: 8911182
    [Abstract] [Full Text] [Related]

  • 7. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C, Haage P, Krombach GA, Schmidt T, Ahaus M, Günther RW, Staatz G.
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [Abstract] [Full Text] [Related]

  • 8. Dynamic MR imaging in Tolosa-Hunt syndrome.
    Haque TL, Miki Y, Kashii S, Yamamoto A, Kanagaki M, Takahashi T, Fushimi Y, Asato R, Murase N, Shibasaki H, Konishi J.
    Eur J Radiol; 2004 Sep; 51(3):209-17. PubMed ID: 15294327
    [Abstract] [Full Text] [Related]

  • 9. [Direct MR arthrography of the wrist in comparison with arthroscopy: a prospective study on 125 patients].
    Schmitt R, Christopoulos G, Meier R, Coblenz G, Fröhner S, Lanz U, Krimmer H.
    Rofo; 2003 Jul; 175(7):911-9. PubMed ID: 12847645
    [Abstract] [Full Text] [Related]

  • 10. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A, Sabatini M, Iannessi F, Di Cesare E, Splendiani A, Calvisi V, Masciocchi C.
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S, Imbriaco M, D'Angelillo M, Mollica C, Camera L, Salvatore M.
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [Abstract] [Full Text] [Related]

  • 12. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
    Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD.
    Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
    [Abstract] [Full Text] [Related]

  • 13. Value of subtraction technique in Gd-DTPA-enhanced magnetic resonance angiography of the thoracic aorta.
    O'Connell MJ, Murray JG.
    Clin Radiol; 2001 Jul; 56(7):545-9. PubMed ID: 11446751
    [Abstract] [Full Text] [Related]

  • 14. [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy].
    Spina V, Torricelli P, Manfrini M, Picci P, Romagnoli R.
    Radiol Med; 1993 Jun; 85(6):725-32. PubMed ID: 8337428
    [Abstract] [Full Text] [Related]

  • 15. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H.
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 17. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW, Teifke A, Schreiber WG, Schmidt M, Thelen M.
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [Abstract] [Full Text] [Related]

  • 18. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 19. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML, Makris A, Taylor NJ, Harrison M, Richman PI, Burcombe RJ, Stirling JJ, d'Arcy JA, Collins DJ, Pittam MR, Ravichandran D, Padhani AR.
    Clin Cancer Res; 2008 Oct 15; 14(20):6580-9. PubMed ID: 18927299
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.
    Torricelli P, Pecchi A, Luppi G, Romagnoli R.
    Abdom Imaging; 2003 Oct 15; 28(1):19-27. PubMed ID: 12483379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.